CEL-SCI Corp logo

CEL-SCI Corp

$ 3.45 -0.08 (-2.27%) 04:00 PM EST
P/E:
At Loss
P/B:
3.68
Market Cap:
$ 142.84M
Enterprise V:
$ 140.71M
Volume:
141.31K
Avg Vol (2M):
260.03K
Also Trade In:
Volume:
141.31K
Market Cap $:
142.84M
PE Ratio:
At Loss
Avg Vol (2-Month):
260.03K
Enterprise Value $:
140.71M
PB Ratio:
3.68
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Name Current Vs Industry Vs History
Cash-To-Debt 1.79
Equity-to-Asset 0.68
Debt-to-Equity 0.41
Debt-to-EBITDA -0.5
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.03
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 5.1
3-Year EPS without NRI Growth Rate 20.8
3-Year FCF Growth Rate 4.7
Name Current Vs Industry Vs History
5-Day RSI 39.35
9-Day RSI 37.43
14-Day RSI 40.18
6-1 Month Momentum % -4.85
12-1 Month Momentum % -65.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.71
Quick Ratio 7.17
Cash Ratio 6.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.5
Name Current Vs Industry Vs History
ROE % -73.03
ROA % -52.63
ROIC % -120.29
ROC (Joel Greenblatt) % -126.67
ROCE % -53.34

Financials (Next Earnings Date:2022-11-15 Est.)

CVM's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:CVM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.85
Beta 0.37
Volatility % 66.34
14-Day RSI 40.18
14-Day ATR ($) 0.296331
20-Day SMA ($) 3.8695
12-1 Month Momentum % -65.4
52-Week Range ($) 2.49 - 12.82
Shares Outstanding (Mil) 43.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CEL-SCI Corp Filings

Document Form Filing Date
No Filing Data

CEL-SCI Corp Analysis

Share your research

Headlines

See More
No news.